Avita Medical seeks IP review of Renovacare patent

May 11, 2017 By Fink Densford

Avita Medical (ASX:AVH) said yesterday it filed an Inter Partes review petition against a patent held by RenovaCare.

The company said it filed the IPR challenge with the US Patent Trial and Appeal Board for US Patent No. 9,610,430 owned by Renovacare.

“We believe we have presented a very strong rationale to the PTAB as to why this patent should never have been issued, and thus, we respectfully request that all claims in the ‘430 patent should be cancelled. Avita is a pioneer in the regenerative medicine arena, and we are very protective of our intellectual property rights,” Avita CEO Adam Kelliher said in a press release.

Avita Medical has not yet said what the patent it has filed the petition against is related to.

Last month, Avita Medical saw shares jump as much as 7% after the FDA approved an expansion to the number of patients that can be treated in a trial of its ReCell regenerative device.

The ReCell device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, reconstructive and cosmetic procedures, the company said.

January 2021 Issue: The Leadership in Medical Technology Issue
9 lessons in crisis management from Stryker CEO Kevin Lobo These 10 stories mattered the most for medtech in 2020 How ResMed is advancing sleep and respiratory care How Dexcom CEO Kevin Sayer is leading the company forward Black engineers group works to promote diversity in medtech, equity in healthcare Taking the guesswork out of… […]
Olympus recalls thousands of endo devices due to packaging defect
Olympus is recalling approximately 26,000 disposable EndoTherapy devices because of a packaging defect that could compromise their sterility. The announcement affects113 models distributed in the U.S.since early 2019, with different numbers of SKUs available in different regions worldwide. The company is asking customers to quarantine the devices until they can be shipped back to Olympus.… […]
FDA says to limit mask decontamination to 4 cycles
Soon after healthcare workers began warning of personal protective equipment (PPE) shortages, companies and other organizations started claiming their decontamination systems could reprocess used filtering facepiece respirators (FFRs) such as N95s up to 20 times. The FDA began issuing emergency use authorizations (EUAs) for FFR decontamination systems with a range of allowable cycles and major… […]
5 innovations to make duodenoscopes more single-use — and save lives
Duodenoscopes are important medical devices that are used for endoscopic retrograde cholangiopancreatography (ERCP) procedures. However, the devices have had serious problems in the past. Luckily, several medical device companies have stepped in to solve the problems. Duodenoscopes are flexible, lighted tubes threaded through the mouth, throat and stomach into the top of the small intestine.… […]
Plastic Molding Manufacturing adds 5 molding machines
Plastic Molding Manufacturing (Hudson, Mass.) announced that it has added five new injection molding and two coordinate measuring machines in upgrades to its manufacturing and quality operations. The $1 million-plus investment will enable the custom molding company to distribute the pair of 214-ton machines, two 259-ton machines, and a 101-ton machine throughout its manufacturing network,… […]
CytoSorbents names former Integra exec to regulatory post
Blood purification tech manufacturer CytoSorbents (NSDQ:CTSO)announced the appointment of David D. Cox as VP of global regulatory affairs. Cox was most recently VP of regulatory affairs for tissue and regenerative technologies at Integra LifeSciences (NSDQ:IART). He was responsible for regulatory approvals of new products and product extensions for the $480 million orthopedics and tissue technologies division.… […]
FDA clears Siemens’ radiography systems
Siemens Healthineers (ETR: SHL) announced that the FDA has cleared its Multix Impact C ceiling-mounted digital radiography (DR) system as well as the Multix Impact VA20, a new version of the established floor-mounted parent DR system. The Multix Impact C and the Multix Impact VA20 were designed with an intuitive operating system, versatile wireless detectors, motorized tube… […]
7 takeaways from Biden’s ‘full-scale, wartime’ plan to combat the COVID-19 pandemic
President Joe Biden kept to his word to announce plans to “establish clear federal leadership” to tackle the coronavirus pandemic on his first full day in office. The White House issued a 200-page document on Inauguration Day detailing “full-scale, wartime” plans to harness the nation’s manufacturing and distribution capabilities to boost vaccine production, end shortages… […]
Qosina adds 12 new fluid and gas filters
OEM single-use component supplier Qosina announced earlier this month that it added 12 new filter options for fluid and gas applications. Ronkonkoma, N.Y.-based Qosina’s filter product line includes offerings across a range of hydrophilic and hydrophobic filters, transducer protectors and an assortment of NRFit filters that are compliant with the ISO 80369-6 standard, according to… […]
OmniGuide launches surgical laser system fiber
OmniGuide today announced the FDA clearance and commercial launch of its new OTO-U CO2 laser system fiber for use in ENT and otology surgery. The new fiber is designed to enable the surgeon to get into a tighter space with more precision and improve procedure outcomes, according to the Lexington, Mass.-based company. “OTO-U surgical fiber… […]
Biden’s COVID-19 response will make manufacturers busy
Manufacturers of vaccine supplies and personal protective equipment can expect more work as the new Biden administration rolls out its “full-scale, wartime” plans to combat the COVID-19 pandemic. In one of his first official acts as president, Joe Biden announced a plan to “fully use” the Defense Production Act to ramp up manufacturing of testing… […]